GE HealthCare Stocks Dive 14% Amid China's Rare Earth Export Ban Shockwave
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, critical for medical technology, amid escalating US-China trade tensions.
GE HealthCare's stock fell 14% after China announced export controls on rare earth materials, critical for medical technology, amid escalating US-China trade tensions.
GE HealthCare's shares fell 14% after China announced export controls on rare earth materials, crucial for medical imaging equipment, amid US-China trade tensions.
GE HealthCare Technologies, Inc. sees a 14% stock drop after China announces rare earth export controls, sparking supply chain fears in healthcare technology.
GE HealthCare's stock price fell by 14.02% to $61.9050 following China's ban on rare earth exports, signaling potential disruptions in global supply chains and the healthcare techn...